CyberKnife radiosurgery for prostate cancer

Technology in Cancer Research and Treatment

Volumn 9, Issue 5, 2010, Pages 463-472

  Katz, Alan J ^a  

^a Flushing Radiation Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN;

ANTIANDROGEN THERAPY; BRACHYTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CYBERKNIFE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECTUM HEMORRHAGE; REVIEW; SEXUAL FUNCTION; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME;

EID: 78049236942     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303461000900504     Document Type: Review

References (52)

1. Gagnon, G. J., Nasr, N. M., Liao, J. J., Molzahn, I., Marsh, D., McRae, D., Henderson, F. C., Sr. Treatment of spinal tumors using cyberknife fractionated stereotactic radiosurgery: pain and quality-of-life assessment after treatment in 200 patients. Neurosurgery 64, 297-306; discussion 306-297 (2009).
2. Rusthoven, K. E., Kavanagh, B. D., Cardenes, H., Stieber, V. W., Burri, S. H., Feigenberg, S. J., Chidel, M. A., Pugh, T. J., Franklin, W., Kane, M., Gaspar, L. E., Schefter, T. E. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27, 1572-1578 (2009).
3. Svedman, C., Karlsson, K., Rutkowska, E., Sandstrom, P., Blomgren, H., Lax, I., Wersall, P. Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney. Acta Oncol 47, 1578-1583 (2008).
4. Timmerman, R., Paulus, R., Galvin, J., Michalski, J., Straube, W., Bradley, J., Fakiris, A., Bezjak, A., Videtic, G., Johnstone, D., Fowler, J., Gore, E., Choy, H. Stereotactic body radiation therapy for inoperable early stage lung cancer. Jama 303, 1070-1076.
5. Martin, A., Gaya, A. Stereotactic body radiotherapy: a review. Clin Oncol (R Coll Radiol) 22, 157-172.
6. Stereotactic Body Radiation Therapy (SBRT) for the Definitive Management of Early-Stage, Low-Intermediate Risk Prostate Cancer [http://www.astro.org/ HealthPolicy/EmergingTechnology/EvaluationProjects/documents/SBRTPosit.pdf]
7. Buyyounouski, M. K., Price, R. A., Jr., Harris, E. E., Miller, R., Tome, W., Schefter, T., Parsai, E. I., Konski, A. A., Wallner, P. E. Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee. Int J Radiat Oncol Biol Phys 76, 1297-1304.
8. King, C. R., Brooks, J. D., Gill, H., Pawlicki, T., Cotrutz, C., Presti, J. C., Jr. Stereotactic Body Radiotherapy for Localized Prostate Cancer: Interim Results of a Prospective Phase II Clinical Trial. Int J Radiat Oncol Biol Phys 73, 1043-1048 (2009).
9. Friedland, J. L., Freeman, D. E., Masterson-McGary, M. E., Spellberg, D. M. Stereotactic body radiotherapy: an emerging treatment approach for localized prostate cancer. Technol Cancer Res Treat 8, 387-392 (2009).
10. Katz, A. J., Santoro, M., Ashley, R., Diblasio, F., Witten, M. Stereotactic body radiotherapy for organ-confined prostate cancer. BMC Urol 10, 1 (2010).
11. Townsend, N. C., Huth, B. J., Ding, W., Garber, B., Mooreville, M., Arrigo, S., Lamond, J., Brady, L. W. Acute Toxicity After CyberKnife-Delivered Hypofractionated Radiotherapy for Treatment of Prostate Cancer. Am J Clin Oncol (In Press).
12. Fuller, D. B., Naitoh, J., Reilly, M., Lee, C. Virtual HDR Prostate CyberKnife Radiosurgery: Efficacy, Toxicity and Quality of Life In: 2009 CyberKnife Users' Meeting. Hollywood, FL (2009).
13. Eade, T. N., Hanlon, A. L., Horwitz, E. M., Buyyounouski, M. K., Hanks, G. E., Pollack, A. What dose of external-beam radiation is high enough for prostate cancer? Int J Radiat Oncol Biol Phys 68, 682-689 (2007). (Pubitemid 46818746)
14. Kupelian, P. A., Thakkar, V. V., Khuntia, D., Reddy, C. A., Klein, E. A., Mahadevan A. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. Int J Radiat Oncol Biol Phys 63, 1463-1468 (2005).
15. Zelefsky, M. J., Chan, H., Hunt, M., Yamada, Y., Shippy, A. M., Amols, H. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 176, 1415-1419 (2006). (Pubitemid 44307191)
16. Fowler, J. F., Ritter, M. A., Chappell, R. J., Brenner, D. J. What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys 56, 1093-1104 (2003).
17. Brenner, D. J., Martinez, A. A., Edmundson, G. K., Mitchell, C., Thames, H. D., Armour, E. P. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 52, 6-13 (2002).
18. Fowler, J. F. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 44, 265-276 (2005).
19. Brenner, D. J. Fractionation and late rectal toxicity. Int J Radiat Oncol Biol Phys 60, 1013-1015 (2004).
20. Collins, C. D., Lloyd-Davies, R. W., Swan, A. V. Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique. Clin Oncol (R Coll Radiol) 3, 127-132 (1991).
21. Cahlon, O., Zelefsky, M. J., Shippy, A., Chan, H., Fuks, Z., Yamada, Y., Hunt, M., Greenstein, S., Amols, H. Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys 71, 330-337 (2008).
22. Martinez, A. A., Demanes, J., Vargas, C., Schour, L., Ghilezan, M., Gustafson, G. S. High-Dose-Rate Prostate Brachytherapy: An Excellent Accelerated-Hypofractionated Treatment for Favorable Prostate Cancer. Am J Clin Oncol (2009).
23. Demanes, D. J., Rodriguez, R. R., Schour, L., Brandt, D., Altieri, G. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys 61, 1306-1316 (2005).
24. Madsen, B. L., His, R. A., Pham, H. T., Fowler, J. F., Esagui, L., Corman, J. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys 67, 1099-1105 (2007). (Pubitemid 46320084)
25. Romanelli, P., Schaal, D.W., Adler, J. R. Image-guided radiosurgical ablation of intra- and extra-cranial lesions. Technol Cancer Res Treat 5, 421-428 (2006).
26. King, C. R., Lehmann, J., Adler, J. R., Hai, J. CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility. Technol Cancer Res Treat 2, 25-29 (2003).
27. Hossain, S., Xia, P., Huang, K., Descovich, M., Chuang, C., Gottschalk, A. R., Roach, M., III, Ma, L. Dose Gradient Near Target-Normal Structure Interface for Nonisocentric CyberKnife and Isocentric Intensity-Modulated Body Radiotherapy for Prostate Cancer. Int J Radiat Oncol Biol Phys (In press).
28. Hossain, S., Xia, P., Chuang, C., Verhey, L., Gottschalk, A. R., Mu, G., Ma, L. Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT. Med Phys 35, 4041-4048 (2008).
29. Xie, Y., Djajaputra, D., King, C. R., Hossain, S., Ma, L., Xing, L. Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys 72, 236-246 (2008).
30. Choi, C., Cho, G., Kim, K., Park, M., Jo, C., Lee, S., Yoo, M., Kim, K., Yang, H. Stereotactic Radiation Therapy of Localized Prostate Cancer Using CyberKnife. Int J Radiat Oncol Biol Phys 69, S375 (2007).
31. Freeman, D. E., Friedland, J. L., Masterson-McGary, M. E. Stereotactic Radiosurgery for Low-Intermediate Risk Prostate Cancer: An Emerging Treatment Approach. Am J Clin Oncol 33, 208 (2010).
32. Sanda, M. G, Dunn, R. L, Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., Mahadevan, A., Klein, E., Kibel, A., Pisters, L. L., Kuban, D., Kaplan, I., Wood, D., Ciezki, J., Shah, N., Wei, J. T. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358, 1250-1261 (2008).
33. Katz, A., Santoro, M. CyberKnife radiosurgery for early carcinoma of the prostate: A three year experience. Int J Radiat Oncol Biol Phys 75, S312-S313 (2009).
34. Fuller, D. B., Naitoh, J., Lee, C., Hardy, S., Jin, H. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Int J Radiat Oncol Biol Phys 70, 1588-1597 (2008).
35. Meier, R., Cotrutz, C. MRI-planned Stereotactic Body Radiotherapy for Organ-confined Prostate Cancer: Feasibility and Early Results Int J Radiat Oncol Biol Phys 75, S334 (2009).
36. Wiegner, E. A., King, C. R. Sexual Function after Stereotactic Body Radiotherapy for Prostate Cancer: Results of a Prospective Clinical Trial. Int J Radiat Oncol Biol Phys (In Press).
37. Martinez, A. A., Gustafson, G., Gonzalez, J., Armour, E., Mitchell, C., Edmundson, G., Spencer, W., Stromberg, J., Huang, R., Vicini, F. Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 53, 316-327 (2002).
38. Katz, A., Santoro, M., Ashley, R., Diblasio, F., Witten, M. Stereotactic Body Radiotherapy as Boost for Organ-Confined Prostate Cancer. Technol Cancer Res Treat (In press).
39. CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry [http://clinicaltrials.gov/ct2/show/ NCT00643617]
40. CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution [http://clinicaltrials.gov/ct2/show/NCT00643994]
41. Fowler, J. F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62, 679-694 (1989).
42. King, C. R., Lo, A., Kapp, D. S. Testicular dose from prostate cyberknife: a cautionary note. Int J Radiat Oncol Biol Phys 73, 636-637; author reply 637 (2009).
43. Fuller, D. B. Testicular dose from prostate cyberknife: a cautionary note in regard to King et al., Int J Radiat Oncol Biol Phys 73, 637 (2009).
44. Yogeswaren, S., The, B., Mai, W., Childress, C., McGary, J., Grant, W., Butler, E. Radiation dose to testicles and serum testosterone levels in low risk prostate cancer patients undergoing intensity-modulated radiation therapy (IMRT) Int J Radiat Oncol Biol Phys 60, S456 (2004).
45. Sannazzari, G. L., Ragona, R., Ruo Redda, M. G., Giglioli, F. R., Isolato, G., Guarneri, A. CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. Br J Radiol 75, 603-607 (2002).
46. Martinez, A. A., Demanes, D. J., Galalaem, R., Vargas, C., Bertermann, H., Rodriguez, R., Gustafson, G., Altieri, G., Gonzalez, J. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Int J Radiat Oncol Biol Phys 62, 1322-1331 (2005).
47. Roach, M., III, DeSilvio, M., Valicenti, R., Grignon, D., Asbell, S. O., Lawton, C., Thomas, C. R., Jr., Shipley, W. U. Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. Int J Radiat Oncol Biol Phys 66, 647-653 (2006).
48. Pommier, P., Chabaud, S., Lagrange, J. L., Richaud, P., Lesaunier, F., Le Prise, E., Wagner, J. P., Hay, M. H., Beckendorf, V., Suchaud, J. P., Pabot du Chatelard, P. M., Bernier, V., Voirin, N., Perol, D., Carrie, C. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01. J Clin Oncol 25, 5366-5373 (2007).
49. Zelefsky, M. J., Shi, W., Yamada, Y., Kollmeier, M. A., Cox, B., Park, J., Seshan, V. E. Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality. Int J Radiat Oncol Biol Phys 75, 1350-1356 (2009).
50. Pollack, A., Zagars, G. K. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys 39, 1011-1018 (1997). (Pubitemid 27506151)
51. Zelefsky, M. J., Leibel, S. A., Gaudin, P. B., Kutcher, G. J., Fleshner, N. E., Venkatramen, E. S., Reuter, V. E., Fair, W. R., Ling, C. C., Fuks, Z. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41, 491-500 (1998).
52. Hanks, G. E., Hanlon, A. L., Pinover, W. H., Horwitz, E. M., Price, R. A., Schultheiss, T. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys 46, 823-832 (2000).